Accurately prevent SARS-CoV-2 infections based on the basic principles of infectious disease prevention and control

Qing MAO

doi:10.16016/j.1000-5404.202112023

您当前的位置：

首页 >

文章列表页 >

Accurately prevent SARS-CoV-2 infections based on the basic principles of infectious disease prevention and control

Public Health and Preventive Medicine | 更新时间：2026-01-09

- Accurately prevent SARS-CoV-2 infections based on the basic principles of infectious disease prevention and control
- Journal of Army Medical University Vol. 44, Issue 1, Pages: 28-33(2022)
- 作者机构：
  
  400038 重庆，陆军军医大学（第三军医大学）第一附属医院感染病科，全军感染病研究所
- 作者简介：
- 基金信息：
- DOI：10.16016/j.1000-5404.202112023
  CLC： R183;R512.99
- Received：03 December 2021，
  
  Revised：2021-12-14，
  
  Published：15 January 2022
- 稿件说明：
移动端阅览
Qing MAO. Accurately prevent SARS-CoV-2 infections based on the basic principles of infectious disease prevention and control[J]. Journal of Army Medical University, 2022, 44(1): 28-33.
DOI：

Qing MAO. Accurately prevent SARS-CoV-2 infections based on the basic principles of infectious disease prevention and control[J]. Journal of Army Medical University, 2022, 44(1): 28-33. DOI： 10.16016/j.1000-5404.202112023.

摘要

新型冠状病毒肺炎（简称新冠肺炎，coronavirus disease 2019，COVID-19）疫情暴发流行已两年，持续在全世界肆虐。由于各国采取的防控政策和措施不同，疫苗分配不均，加之新型冠状病毒（severe acute respiratory syndrome coronavirus 2

SARS-CoV-2）变异迅速，导致疫情仍十分严重。随着疫情的发展，对新冠肺炎的临床特征、流行病学及SARS-CoV-2的生物学特征等有了深入研究和认识。人群普遍接种疫苗在控制新冠肺炎疫情中起到决定性作用，但注射疫苗后仍然存在一定比例的突破性感染。因此，依据传染病防控基本原则（管理传染源、切断传播途径、保护易感人群）进行物理防护仍十分重要。实践证明，“普遍疫苗接种+有效物理防护”是全面控制新冠肺炎疫情的根本措施，两者不可或缺。

Abstract

The novel coronavirus pneumonia (coronavirus disease 2019

COVID-19) pandemic has been raging around the world for almost 2 years. Due to the different prevention and control policies and measures adopted by various countries

uneven distribution of vaccines and rapid mutation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

the pandemic is still very serious. With the process of the pandemic

in-depth research and understanding of the clinical characteristics and epidemiology of COVID-19 and biological characteristics of SARS-CoV-2 have been made. Widespread vaccination of the population plays a decisive role in the control of the COVID-19 pandemic. However

there is still a certain percentage of breakthrough infections after vaccination. Therefore

the physical protection is still very important based on the basic principles of infectious disease prevention and control (management of the source of infection

cutting off the route of transmission and protection of the susceptible population). Practice has proved that "widespread vaccination + effective physical precautions" is a fundamental measure for comprehensive control of COVID-19 pandemic

and both are indispensable.

关键词

Keywords

references

WHO Coronavirus (COVID-19) Dashboard[R/OL]. [2021-12-01]. https://covid19.who.int/.

COVID-19 advice for the public: Getting vaccinated[EB/OL]. (2021-11-15)[2021-12-08]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice.

CDC COVID-19 Vaccine Breakthrough Case Investigations Team. COVID-19 vaccine breakthrough infections reported to CDC—United States, January 1-April 30, 2021[J]. MMWR Morb Mortal Wkly Rep, 2021, 70(21): 792-793. DOI: 10.15585/mmwr.mm7021e3.

ROVIDA F, CASSANITI I, PAOLUCCI S, et al . SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers[J ] . Nat Commun, 2021, 12(1): 6032. DOI: 10.1038/s41467-021-26154-6.

CEVIK M, TATE M, LLOYD O, et al . SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis[J ] . Lancet Microbe, 2021, 2(1): e13-e22. DOI: 10.1016/S2666-5247(20)30172-5.

CEVIK M, KUPPALLI K, KINDRACHUK J, et al . Virology, transmission, and pathogenesis of SARS-CoV-2[J ] . BMJ, 2020: m3862. DOI: 10.1136/bmj.m3862.

ZHENG S F, FAN J, YU F, et al . Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang Province, China, January-March 2020: retrospective cohort study[J ] . BMJ, 2020: m1443. DOI: 10.1136/bmj.m1443.

MEYEROWITZ E A, RICHTERMAN A, BOGOCH I I, et al . Toward s an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2[J ] . Lancet Infect Dis, 2021, 21(6): e163-e169. DOI: 10.1016/s1473-3099(20)30837-9.

BUITRAGO-GARCIA D, EGLI-GANY D, COUNOTTE M J, et al . Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis[J ] . PLoS Med, 2020, 17(9): e1003346. DOI: 10.1371/journal.pmed.1003346.

LAVEZZO E, FRANCHIN E, CIAVARELLA C, et al . Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'[J ] . Nature, 2020, 584(7821): 425-429. DOI: 10.1038/s41586-020-2488-1.

国家卫生健康委宣传司. 国务院联防联控机制2021年11月6日新闻发布会文字实录[EB/OL]. (2021-11-06)[2021-12-08]. http://www.nhc.gov.cn/xcs/fkdt/202111/28aeb8577b8747ed877f582d50f51035.shtml.

Publicity Department of National Health Commission. Transcript of the press conference of the joint prevention and control mechanism of the State Council on November 6, 2021[EB/OL]. (2021-11-06)[2021-12-08]. http://www.nhc.gov.cn/xcs/fkdt/202111/28aeb8577b8747ed877f582d50f51035.shtml.

金振娅. 对返校学生"适时抽检"——教育部向全国推广福建防疫"实招"[N/OL]. 光明日报, 2021-09-17[2021-12-08]. http://www.moe.gov.cn/jyb_xwfb/s5147/202109/t20210917_564006.html.

JIN Z Y. "Sampling inspections at the right time" for returning students—the Ministry of Education promotes Fujian's "practical measures" for epidemic prevention throughout the country[N/OL]. Guangming Daily, 2021-09-17[2021-12-08]. http://www.moe.gov.cn/jyb_xwfb/s5147/202109/t20210917_564006.html.

国务院应对新型冠状病毒肺炎疫情联防联控机制综合组. 新型冠状病毒肺炎防控方案(第八版)[R/OL]. (2021-05-14)[2021-12-08]. http://www.nhc.gov.cn/xcs/zhengcwj/202105/6f1e8ec6c4a540d99fafef52fc86d0f8.shtml.

The Joint Prevention and Control Group of the State Council Against New Coronavirus Pneumonia. New coronavirus pneumonia prevention and control plan (8th Edition)[R/OL]. (2021-05-14)[2021-12-08]. http://www.nhc.gov.cn/xcs/zhengcwj/202105/6f1e8ec6c4a540d99fafef52fc86d0f8.shtml.

国家卫生健康委办公厅, 国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第八版修订版)[R/OL]. (2021-04-15)[2021-12-08]. http://www.nhc.gov.cn/yzygj/s7653p/202104/7de0b3837c8b4606a0594aeb0105232b.shtml.

General Office of National Health Commission, Office of the State Administration of Traditional Chinese Medicine.New coronavirus pneumonia diagnosis and treatment plan (Trial 8th Edition, Revised)[R/OL]. (2021-04-15)[2021-12-08]. http://www.nhc.gov.cn/yzygj/s7653p/202104/7de0b3837c8b4606a0594aeb0105232b.shtml.

MORAWSKA L, CAO J. Airborne transmission of SARS-CoV-2: The world should face the reality[J]. Environ Int, 2020, 139: 105730. DOI: 10.1016/j.envint.2020.105730.

LEE B U. Why does the SARS-CoV-2 delta VOC spread so rapidly? Universal conditions for the rapid spread of respiratory viruses, minimum viral loads for viral aerosol generation, effects of vaccination on viral aerosol generation, and viral aerosol clouds[J]. Int J Environ Res Public Heal, 2021, 18(18): 9804. DOI: 10.3390/ijerph18189804.

HAMMING I, TIMENS W, BULTHUIS M L, et al . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis[J ] . J Pathol, 2004, 203(2): 631-637. DOI: 10.1002/path.1570.

HIKMET F, MÉAR L, EDVINSSON Å, et al . The protein expression profile of ACE2 in human tissues[J ] . Mol Syst Biol, 2020, 16(7): e9610. DOI: 10.15252/msb.20209610.

KYROU I, RANDEVA H S, SPANDIDOS D A, et al . Not only ACE2-the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19[J ] . Signal Transduct Target Ther, 2021, 6(1): 1-3. DOI: 10.1038/s41392-020-00460-9.

DAVIES J, RANDEVA H S, CHATHA K, et al . Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19[J ] . Mol Med Rep, 2020, 22(5): 4221-4226. DOI: 10.3892/mmr.2020.11510.

XIE X, LI Y, CHWANG A T, et al . How far droplets can move in indoor environments: revisiting the Wells evaporation-falling curve[J ] . Indoor Air, 2007, 17(3): 211-225. DOI: 10.1111/j.1600-0668.2007.00469.x.

The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020[J]. China CDC Wkly, 2020, 2(8): 113-122.

STOKES E K, ZAMBRANO L D, ANDERSON K N, et al . Coronavirus disease 2019 case surveillance—United States, January 22-may 30, 2020[J ] . MMWR Morb Mortal Wkly Rep, 2020, 69(24): 759-765. DOI: 10.15585/mmwr.mm6924e2.

KHAN M I, BAIG M H, MONDAL T, et al . Impact of the double mutants on spike protein of SARS-CoV-2 B. 1.617 lineage on the human ACE2 receptor binding: a structural insight[J ] . Viruses, 2021, 13(11): 2295. DOI: 10.3390/v13112295.

Scientific Advisory Group for Emergencies. Imperial College London: Delta (B. 1.617.2) transmission in England-risk factors and transmission advantage, 1 June 2021[R/OL]. (2021-06-14)[2021-12-08]. https://www.gov.uk/government/publications/imperial-college-london-delta-b16172-transmission-in-england-risk-factors-and-transmission-advantage-1-june-2021.

POLACK F P, THOMAS S J, KITCHIN N, et al . Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine[J ] . N Engl J Med, 2020, 383(27): 2603-2615. DOI: 10.1056/nejmoa2034577.

BADEN L R, SAHLY H M EL, ESSINK B, et al . Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine[J ] . N Engl J Med, 2021, 384(5): 403-416. DOI: 10.1056/NEJMoa2035389.

XIA S L, ZHANG Y T, WANG Y X, et al . Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial[J ] . Lancet Infect Dis, 2021, 21(1): 39-51. DOI: 10.1016/S1473-3099(20)30831-8.

ZHANG Y J, ZENG G, PAN H X, et al . Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical tria l[J ] . Lancet Infect Dis, 2021, 21(2): 181-192. DOI: 10.1016/S1473-3099(20)30843-4.

LOPEZ BERNAL J, ANDREWS N, GOWER C, et al . Effectiveness of covid-19 vaccines against the B. 1.617.2 (delta) variant[J ] . N Engl J Med, 2021, 385(7): 585-594. DOI: 10.1056/nejmoa2108891.

TANG P, HASAN M R, CHEMAITELLY H, et al . BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar[J ] . Nat Med, 2021: 1-8. DOI: 10.1038/s41591-021-01583-4.

CALLAWAY E. Heavily mutated Omicron variant puts scientists on alert[J]. Nature, 2021, 600(7887): 21. DOI: 10.1038/d41586-021-03552-w.

MIZRAHI B, LOTAN R, KALKSTEIN N, et al . Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine[J ] . Nat Commun, 2021, 12(1): 6379. DOI: 10.1038/s41467-021-26672-3.

KESKIN A U, BOLUKCU S, CIRAGIL P, et al . SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen[J ] . J Med Virol, 2022, 94(1): 39-41. DOI: 10.1002/jmv.27350.

WHO. With a fast-moving pandemic, no one is safe, unless everyone is safe[EB/OL]. [2021-12-08].https://www.who.int/initiatives/act-accelerator/covax.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effective prevention, early diagnosis and precise treatment of gastric cancer

Epidemiological survey and risk factor analysis of extensively drug-resistant Klebsiella pneumoniae infections

Establishment ofaBALB/c mouse model of melioidosis induced by chronic Burkholderia pseudomallei infection

Survey on foot and ankle training injuries of Ⅲ personnel in a certain army during long-distance march

Risk factors for postoperative infection after open wedge high tibial osteotomy: an analysis of 114 cases

Related Author

WANG Bin

WANG Tao

Xiaolang TIAN

Xiaojiong JIA

Liping ZHANG

Tengfei Ma

Yi Hu

Yao Fang

Related Institution

Department of Gastroenterology， Chongqing Key Laboratory of Precise Prevention and Treatment of Digestive Malignancies， Army Medical Center of PLA/Daping Hospital of Third Military Medical University

First Clinical College, the First Affiliated Hospital of Chongqing Medical University

Department of Clinical Laboratory, the First Affiliated Hospital of Chongqing Medical University

Department of Clinical Microbiology and Immunology, College of Medical Laboratory Sciences, Southwest Hospital, Third Military Medical University

Department of Anesthesiology, the Affiliated Hospital of Southwest Medical University

⁰